Pioglitazone, a potent and selective PPAR-γ agonist, can improve insulin sensitivity and enhance hyperglycemia [5]; thus, it has been widely used for treatment on type 2 diabetes mellitus (T2DM) [6]. The gene discussed is INS; the disease is type 2 diabetes mellitus.